COVID-19 interventional trials: Analysis of data sharing intentions during a time of pandemic-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

COVID-19 interventional trials: Analysis of data sharing intentions during a time of pandemic

Published:2022-04 Issue: Volume:115 Page:106709
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Larson Kristina,Sim Ida,von Isenburg Megan,Levenstein Marcia,Rockhold Frank,Neumann Stan,D'Arcy Catherine,Graham Elizabeth,Zuckerman David,Li Rebecca

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference11 articles.

1. COVID-19 trials: declarations of data sharing intentions at trial registration and at publication;Li;Trials,2021

2. Data sharing statements for clinical trials: a requirement of the International Committee of Medical Journal Editors;Taichman;Ann. Intern. Med.,2017

3. Trials and tribulations—11 reasons why we need to promote clinical trials data sharing;Butte;JAMA Netw. Open,2021

4. Primed to comply: individual participant data sharing statements on ClinicalTrials.gov;Statham;PLoS One,2020

5. Trialists’ Intent to Share Individual Participant Data as Disclosed at ClinicalTrials.gov;Bergeris,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the discoverability of supporting research materials in ClinicalTrials.gov for US federally funded COVID-19 clinical studies;Journal of the Medical Library Association;2024-07-29

2. An assessment of the informative value of data sharing statements in clinical trial registries;BMC Medical Research Methodology;2024-03-09

3. Evaluating individual participant data plans for ICMJE compliance: A case study at University of Michigan;Journal of the Society for Clinical Data Management;2023-11-08

4. COVID-19 trials were not more likely to report intent to share individual data than non-COVID-19 trials in ClinicalTrials.gov;Journal of Clinical Epidemiology;2023-06

5. Open Science and COVID-19 Randomized Controlled Trials: Examining Open Access, Preprinting, and Data Sharing-Related Practices During the Pandemic;2022-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3